The best regimens for chemo-naïve incurable non-squamous non-small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1–49%: a network meta-analysis

BACKGROUND: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide. There is a rank order of the efficacy and safety of treatment options, including immune checkpoint inhibitors (ICIs), bevacizumab (Bev), and cytotoxic drugs. When patients have low programmed death...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Nobuhiko, Horita, Nobuyuki, Katakura, Seigo, Namkoong, Ho, Kaneko, Ayami, Somekawa, Kouhei, Tagami, Youichi, Watanabe, Keisuke, Hara, Yu, Kobayashi, Nobuaki, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435382/
https://www.ncbi.nlm.nih.gov/pubmed/34584856
http://dx.doi.org/10.21037/tlcr-21-419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435382/
https://www.ncbi.nlm.nih.gov/pubmed/34584856
http://dx.doi.org/10.21037/tlcr-21-419

Ejemplares similares